Filings

Below are the latest summaries of filings submitted to SEC.

ESSA Pharma's Q3 2024 Report: A Deep Dive into Clinical Advancements and Financial Insights

Alpha Metallurgical Resources Q2 2024: A Deep Dive into Financial Performance and Market Trends

Mesa Laboratories Q1 2025: A Strong Start with Strategic Acquisitions Boosting Growth

Tanger Inc. Q2 2024 Earnings Report: Insights and Implications

Krystal Biotech's Q2 2024 Earnings Report: Positive Momentum and Future Prospects

Analyzing Design Therapeutics' Q2 2024 SEC 10-Q Filing: Financials and Future Outlook